ABVC BIOPHARMA, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fremont, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ABVC BIOPHARMA, INC. has filed 794 SEC EDGAR filings since 28 Jun 2002

SEC filing history

Showing 201-225 of 583 matching filings.

Per page
25
Current page
9
8-K/A File 001-40700

AMENDMENT TO FORM 8-K

Filing date
03 Apr 2023
Reporting date
31 Mar 2023
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
31 Mar 2023
Reporting date
31 Mar 2023
Next action
Verify source filing
10-K File 001-40700

ANNUAL REPORT

Filing date
31 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
D File 021-474704

D filing

Filing date
02 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
24 Feb 2023
Reporting date
24 Feb 2023
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
16 Feb 2023
Reporting date
16 Feb 2023
Next action
Verify source filing
424B4 File 333-250899

PROSPECTUS SUPPLEMENT NO. 2.

Filing date
15 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-255112

PROSPECTUS SUPPLEMENT NO. 2 .

Filing date
15 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40700

QUARTERLY REPORT

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
21 Oct 2022
Reporting date
21 Oct 2022
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
13 Sep 2022
Reporting date
12 Sep 2022
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
09 Sep 2022
Reporting date
04 Sep 2022
Next action
Verify source filing
424B4 File 333-250899

PROSPECTUS SUPPLEMENT

Filing date
25 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-255112

PROSPECTUS SUPPLEMENT

Filing date
25 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
22 Aug 2022
Reporting date
19 Aug 2022
Next action
Verify source filing
10-Q File 001-40700

QUARTERLY REPORT

Filing date
15 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
14 Jul 2022
Reporting date
14 Jul 2022
Next action
Verify source filing
3

3 filing

Filing date
12 Jul 2022
Reporting date
20 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-84759

SCHEDULE 13D

Filing date
12 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-250899

PROSPECTUS

Filing date
11 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-255112

PROSPECTUS

Filing date
11 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-250899

EFFECT filing

Filing date
23 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-250899

POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1

Filing date
23 Jun 2022
Reporting date
Not listed
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
21 Jun 2022
Reporting date
21 Jun 2022
Next action
Verify source filing
EFFECT File 333-255112

EFFECT filing

Filing date
17 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .